AGRINFO AGRINFO logo

The latest on EU AGRI-Food policies impacting low- and middle-income countries

2025/1560

Approval of a health claim for green kiwifruit Hayward

  • Health claims
  • Labelling

Summary

The European Union (EU) has approved the health claim from Zespri International Limited that consumption of green kiwifruit Hayward contributes to normal bowel function by increasing stool frequency.

EU approves green kiwifruit Hayward health claim

Commission Implementing Regulation (EU) 2025/1560 of 30 July 2025 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children’s development and health, and amending Regulation (EU) No 432/2012

Update

The European Union (EU) has approved the health claim from Zespri International Limited that consumption of green kiwifruit Hayward contributes to normal bowel function by increasing stool frequency.

Impacted Products

Green kiwifruit Hayward

What is changing?

The European Commission has approved an application for a health claim submitted by Zespri International Limited that green kiwifruit (Actinidia deliciosa “Hayward”) contributes to normal bowel function by increasing stool frequency. This health claim can only be used if accompanied by additional information stating that “the beneficial effect is obtained with a daily intake of 200 g of fresh green kiwi flesh”.

Why?

The European Food Safety Authority (EFSA 2021) evaluated the proposed claim and concluded that the consumption of green kiwifruit (A. deliciosa “Hayward”) contributes to maintaining normal defecation for the general population.

The health claim complies with the requirements of Regulation 1924/2006 that sets rules on nutrition and health claims made on foods.

Timeline

The health claim is permitted from 20 August 2025.

Background

Regulation 1924/2006 establishes that health claims made on foods have to be authorised by the European Commission and included in the Union list of permitted health claims (Regulation 432/2012). For a health claim to be authorised, EFSA must deliver an opinion on the claim concerned, which the Commission considers when making a decision.

Resources

EFSA (2021) Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 19(6): 6641.

Regulation 1924/2006 on nutrition and health claims made on foods

Regulation 432/2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health

Sources

Commission Implementing Regulation (EU) 2025/1560 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children’s development and health

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.

EU approves green kiwifruit Hayward health claim

Commission Implementing Regulation (EU) 2025/1560 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children’s development and health

What is changing and why?

The European Union (EU) has approved the health claim that consumption of green kiwifruit (Actinidia deliciosa “Hayward”) contributes to normal bowel function by increasing stool frequency. This health claim can only be used if accompanied by additional information stating that “the beneficial effect is obtained with a daily intake of 200 g of fresh green kiwi flesh”.

Timeline

The health claim is permitted from 20 August 2025.

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.